U.S. market Closed. Opens in 1 day 9 hours 25 minutes

INDP | Indaptus Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue1.28K1.78K1.40K852.00854.00K859.00K829.00K701.00K745.90K584.82K602.85K555.43K340.68K367.33K305.53K302.32K
Gross Profit-1.28K-1.78K-1.40K-852.00-854.00K-859.00K-829.00K-701.00K-745.90K-584.82K-602.85K-555.43K-340.68K-367.33K-305.53K-302.32K
Operating Expenses16.38M14.91M7.73M3.60M34.09M42.47M28.61M13.14M6.85M6.98M4.56M4.81M7.42M4.97M3.62M4.61M
Selling, General & Admin8.76M8.59M5.21M944.25K7.43M7.07M4.32M3.07M2.77M2.59M2.41M2.12M2.74M2.65M1.78M1.67M
Research & Development7.62M6.32M2.52M2.66M26.66M35.40M24.30M10.07M4.09M4.39M2.16M2.69M4.69M2.32M1.84M2.94M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-16.38M-14.91M-7.73M-3.60M-34.95M-43.33M-29.44M-13.85M-7.60M-7.57M-5.17M-5.37M-7.76M-5.34M-3.93M-4.91M
Other Expenses / Income955.00K588.11K17.72K15.11K-12.02M-112.00K559.00K484.00K423.40K1.87M72.03K183.07K179.70K-84.94K-16.55K-451.10K
Before Tax Income-15.42M-14.32M-7.71M-3.58M-46.96M-43.44M-28.88M-13.36M-7.18M-5.69M-5.09M-5.18M-7.58M-5.42M-3.94M-5.36M
Income Tax ExpensesN/A-588.11K-17.72K-15.11K638.00K103.00K29.00KN/A-4.00N/AN/AN/AN/AN/AN/AN/A
Net Income-15.42M-13.73M-7.69M-3.57M-47.60M-43.54M-28.91M-13.36M-7.18M-5.69M-5.09M-5.18M-7.58M-5.42M-3.94M-5.36M
Interest ExpensesN/A588.11KN/AN/A15.00K23.00K17.00K16.00KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding8.40M8.26M4.09M486.17K422.20K389.91K220.75K143.10K97.39K3.02M2.68M2.42M2.14M1.71M1.11M716.52K
Diluted Shares Outstanding8.40M8.26M4.09M486.17K422.20K389.91K220.75K143.10K97.39K3.02M2.68M2.42M2.14M1.71M1.11M716.52K
EBITDA-16.38M-14.91M-7.73M-3.60M-46.09M-42.56M-28.61M-13.14M-6.43M-5.11M-4.49M-4.63M-7.24M-5.06M-3.64M-5.06M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-15.42M-13.73M-7.71M-3.58M-46.95M-43.42M-28.86M-13.35M-7.18M-5.69M-5.09M-5.18M-7.58M-5.42M-3.94M-5.36M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙